 Alzamend Neuro ALZN stock is on the move Thursday after getting an update from the U.S. Food and Drug Administration FDA. The post ALZN Stock: The Alzheimers Clinical Trial News That Has Alzamend Neuro Soaring Today appeared first on InvestorPlace. 